Founded on pioneering research by Riitta Lassila and associates at the Wihuri Research Institute in Helsinki, Aplagon is a clinical-stage biopharmaceutical company dedicated to developing first-in-class therapeutics for thromboinflammatory diseases, addressing critical unmet medical needs in vascular medicine.
Its lead therapeutic, APAC, a heparin proteoglycan mimetic, is a dual AntiPlatelet and AntiCoagulant (APAC) with unique antithrombotic and anti-inflammatory properties. Designed to specifically target vascular injury sites, APAC provides localized, long-term action while minimizing systemic exposure.
The company’s clinical pipeline focuses on addressing thromboinflammatory conditions, with lead indications in arteriovenous fistula (AVF) maturation failure for hemodialysis patients and chronic limb threatening ischemia (CLTI) to prevent amputations and major cardiovascular events.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Helsinki
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.aplagon.com
- Keywords
- Thromboinflammatory Diseases, Antithrombotic Therapies, Cardiovascular Disease Research, Clinical-Stage Biopharmaceuticals, APAC Therapeutics, Antiplatelet and Anticoagulant Research, Vascular Inflammation, Hemodialysis Access Failure Prevention, Critical Limb Ischemia Treatment, Peripheral Arterial Disease, Vascular Surgery Innovations, Drug Development, Biopharmaceutical Research, Clinical Trials, Biotechnology Innovations, Life Sciences, Medical Research, Pharmaceutical Development, Healthcare Solutions.
- HQ
- Helsinki
Aplagon Questions
Aplagon's website is http://www.aplagon.com
Aplagon's LinkedIn profile is https://fi.linkedin.com/company/aplagon
Aplagon has
7 employees.
View email and phone details for 7
employees at Aplagon.
Aplagon's industry is
Biotechnology Research
Aplagon's top competitors are
Tepsivo,
Fåhraeus Startup & Growth,
Tilt Biotherapeutics Ltd,
Portage Biotech Inc,
Tectonic Therapeutic, Inc.,
Arivin Therapeutics,
Metsera,
Polku Therapeutics,
Akribion Therapeutics,
Advancell.
Aplagon's categories are Biotechnology Research
Aplagon's founding year is 2009
